Market Access Analytics and Insight
Our Market Research & Analysis service is uniquely tailored for the medical device & Life…
A randomised controlled trial is an experimental study in which participants are allocated by chance to receive the intervention under test or a comparator, so that, on average, the groups differ only in the intervention they receive. Randomisation balances both known and unknown factors between the groups, which is what allows differences in outcome to be attributed to the intervention rather than to confounding, and this protection against bias places well-conducted trials at the top of the evidence hierarchy. Their strength is often reinforced by allocation concealment, blinding and intention-to-treat analysis. For medical devices, randomised trials can be more difficult to conduct because of challenges such as blinding, operator learning curves, and rapid product change, so their design must address these features, and randomised evidence is sometimes complemented by high-quality real-world evidence.
Our Services
NICE HTA Strategy and Submission
Navigate the complexities of NICE Health Technology Assessment (HTA) submissions with our expert strategic guidance.…
Health Economics and Outcomes Research (HEOR)
Specialising in economic modelling for the medical device and life sciences sectors, our HEOR service…
Strategy Development
Leading in market access, Strategy Development from Health Analytical Solutions moves beyond just market entry…
Reimbursement Strategy and Support
Reimbursement Support, tailored for the complex NHS landscape, aids medical device and life sciences companies…
NHS Drug Tariff Submission Support
Our NHS Drug Tariff Submission Service offers specialised expertise in health economics, crucial for navigating…
Private healthcare
Delivering a comprehensive analysis of the UK's private healthcare sector, the Private Healthcare Landscape service…
Value Proposition Development for MedTech
Unlock the potential of your MedTech innovation with our Value Proposition Development service. At Health…
Primary Care Market Insights
Unlock the potential of the primary care market with our in-depth Primary Care Market Insights…
Stakeholder Engagement for Health Technologies
In the complex ecosystem of healthcare, effectively engaging with key stakeholders is fundamental to the…
Sustainability and NET Zero for MedTech
In an era where sustainability is not just an option but a necessity, MedTech companies…
Evidence Generation and Management
In the MedTech sector, the value of an innovation is increasingly measured not just by…
Dashboard Tools for Market Access
Navigating the complexities of market access requires not just data, but insights that can drive…
MedTech Sales Team Empowerment
The UK's National Health Service (NHS) represents a unique and complex market for MedTech sales.…
NHS MedTech Business Case Formulation
Securing NHS adoption for MedTech innovations demands not just outstanding technology but also a compelling…
© Health Analytical Solutions 2026